Long non-coding RNA ARAP1-AS1 contributes to cell proliferation and migration in clear cell renal cell carcinoma via the miR-361-3p/placental growth factor axis

References

• Erman M, Benekli M, Basaran M, et al. Renal cell cancer: overview of the current therapeutic landscape. Expert Rev Anticancer Ther. 2016;16(9):955–968.
   PubMed Web of Science ®Google Scholar
• Tao M, Zhou Y, Jin Y, et al. Blocking lncRNA MIR155HG/miR-155-5p/-3p inhibits proliferation, invasion and migration of clear cell renal cell carcinoma. Pathol Res Pract. 2020;216(2):152803.
   PubMed Web of Science ®Google Scholar
• Hsieh JJ, Purdue MP, Signoretti S, et al. Renal cell carcinoma. Nat Rev Dis Primers. 2017;3(1):17009.
   PubMed Web of Science ®Google Scholar
• Motzer RJ, Hutson TE, McCann L, et al. Overall survival in renal-cell carcinoma with pazopanib versus sunitinib. N Engl J Med. 2014;370(18):1769–1770.
   PubMed Web of Science ®Google Scholar
• Motzer RJ, Escudier B, McDermott DF, et al. Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma. N Engl J Med. 2015;373(19):1803–1813.
   PubMed Web of Science ®Google Scholar
• Glover AR, Zhao JT, Ip JC, et al. Long noncoding RNA profiles of adrenocortical cancer can be used to predict recurrence. Endocr Relat Cancer. 2015;22(1):99–109.
   PubMed Web of Science ®Google Scholar
• Fu M, Zou C, Pan L, et al. Long noncoding RNAs in digestive system cancers: functional roles, molecular mechanisms, and clinical implications (Review). Oncol Rep. 2016;36(3):1207–1218.
   PubMed Web of Science ®Google Scholar
• Niu ZS, Niu XJ, Wang WH. Long non-coding RNAs in hepatocellular carcinoma: potential roles and clinical implications. World J Gastroenterol. 2017;23(32):5860–5874.
   PubMed Web of Science ®Google Scholar
• Pandya G, Kirtonia A, Sethi G, et al. The implication of long non-coding RNAs in the diagnosis, pathogenesis and drug resistance of pancreatic ductal adenocarcinoma and their possible therapeutic potential. Biochim Biophys Acta. 2020;1874(2):188423.
   PubMed Web of Science ®Google Scholar
• Romero-Barrios N, Legascue MF, Benhamed M, et al. Splicing regulation by long noncoding RNAs. Nucleic Acids Res. 2018;46(5):2169–2184.
   PubMed Web of Science ®Google Scholar
• Chen X, Xie R, Gu P, et al. Long Noncoding RNA LBCS Inhibits Self-Renewal and Chemoresistance of Bladder Cancer Stem Cells through Epigenetic Silencing of SOX2. Clin Cancer Res off J Am Assoc Cancer Res. 2019;25(4):1389–1403.
   PubMed Web of Science ®Google Scholar
• Luo H, Xu C, Le W, et al. lncRNA CASC11 promotes cancer cell proliferation in bladder cancer through miRNA-150. J Cell Biochem. 2019;120(8):13487–13493.
   PubMed Web of Science ®Google Scholar
• Zhai W, Zhu R, Ma J, et al. A positive feed-forward loop between LncRNA-URRCC and EGFL7/P-AKT/FOXO3 signaling promotes proliferation and metastasis of clear cell renal cell carcinoma. Mol Cancer. 2019;18(1):81.
   PubMedGoogle Scholar
• Hu Z, Li L, Cheng P, et al. lncRNA MSC-AS1 activates Wnt/beta-catenin signaling pathway to modulate cell proliferation and migration in kidney renal clear cell carcinoma via miR-3924/WNT5A. J Cell Biochem. 2020;121(10):4085–4093.
   PubMed Web of Science ®Google Scholar
• Teng J, Ai X, Jia Z, et al. Long non-coding RNA ARAP1-AS1 promotes the progression of bladder cancer by regulating miR-4735-3p/NOTCH2 axis. Cancer Biol Ther. 2019;20(4):552–561.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wu D, Wang D. Long non-coding RNA ARAP1-AS1 promotes tumorigenesis and metastasis through facilitating proto-oncogene c-Myc translation via dissociating PSF/PTB dimer in cervical cancer. Cancer Med. 2020;9(5):1855–1866.
   PubMed Web of Science ®Google Scholar
• Lu C, Wang X, Zhao X, et al. Long non-coding RNA ARAP1-AS1 accelerates cell proliferation and migration in breast cancer through miR-2110/HDAC2/PLIN1 axis. Biosci Rep. 2020;40(4):4.
   Google Scholar
• Yin Z, Wang W, Qu G, et al. MiRNA-96-5p impacts the progression of breast cancer through targeting FOXO3. Thorac Cancer. 2020;11(4):956–963.
   PubMed Web of Science ®Google Scholar
• Chen JY, Xu LF, Hu HL, et al. MiRNA-215-5p alleviates the metastasis of prostate cancer by targeting PGK1. Eur Rev Med Pharmacol Sci. 2020;24(2):639–646.
   PubMed Web of Science ®Google Scholar
• Yang L, Ma HL. MiRNA-584 suppresses the progression of ovarian cancer by negatively regulating LPIN1. Eur Rev Med Pharmacol Sci. 2020;24(3):1062–1071.
   PubMed Web of Science ®Google Scholar
• Chen L, Nan A, Zhang N, et al. Circular RNA 100146 functions as an oncogene through direct binding to miR-361-3p and miR-615-5p in non-small cell lung cancer. Mol Cancer. 2019;18(1):13.
   PubMed Web of Science ®Google Scholar
• Xu J, Yang B, Wang L, et al. LncRNA BBOX1-AS1 upregulates HOXC6 expression through miR-361-3p and HuR to drive cervical cancer progression. Cell Prolif. 2020;53(7):e12823.
   PubMed Web of Science ®Google Scholar
• Xia F, Chen Y, Jiang B, et al. Hsa_circ_0011385 accelerates the progression of thyroid cancer by targeting miR-361-3p. Cancer Cell Int. 2020;20(1):49.
   PubMed Web of Science ®Google Scholar
• Liu J, Zhu J, Xiao Z, et al. BBOX1-AS1 contributes to colorectal cancer progression by sponging hsa-miR-361-3p and targeting SH2B1. FEBS Open Bio. 2020. doi:10.1002/2211-5463.12802.
   Web of Science ®Google Scholar
• Sun Z, Zhang A, Hou M, et al. RNA hsa_circ_0000034 promotes the progression of retinoblastoma via sponging microRNA-361-3p. Bioengineered. 2020;11(1):949–957.
   PubMed Web of Science ®Google Scholar
• Maglione D, Guerriero V, Viglietto G, et al. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci U S A. 1991;88(20):9267–9271.
   PubMed Web of Science ®Google Scholar
• Zhang CY, Yu MS, Li X, et al. Overexpression of long non-coding RNA MEG3 suppresses breast cancer cell proliferation, invasion, and angiogenesis through AKT pathway. Tumour Biol. 2017;39(6):1010428317701311.
   Google Scholar
• Natsume M, Shimura T, Iwasaki H, et al. Placental growth factor is a predictive biomarker for ramucirumab treatment in advanced gastric cancer. Cancer Chemother Pharmacol. 2019;83(6):1037–1046.
   PubMed Web of Science ®Google Scholar
• Taylor AP, Leon E, Goldenberg DM. Placental growth factor (PlGF) enhances breast cancer cell motility by mobilising ERK1/2 phosphorylation and cytoskeletal rearrangement. Br J Cancer. 2010;103(1):82–89.
   PubMed Web of Science ®Google Scholar
• Wei SC, Liang JT, Tsao PN, et al. Preoperative serum placenta growth factor level is a prognostic biomarker in colorectal cancer. Dis Colon Rectum. 2009;52(9):1630–1636.
   PubMed Web of Science ®Google Scholar
• He C, Zhu K, Bai X, et al. Placental Growth Factor Mediates Crosstalk Between Lung Cancer Cells and Tumor-Associated Macrophages in Controlling Cancer Vascularization and Growth. Cell Physiol Biochem. 2018;47(6):2534–2543.
   PubMedGoogle Scholar
• Cechova M, Chocholaty M, Babjuk M, et al. Diagnostic and prognostic value of placental growth factor serum concentration in clear cell renal cell carcinoma. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2021. DOI:10.5507/bp.2021.003.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Yang HF, Wang ZL, Mao TT, et al. Cullin 4B regulates cell survival and apoptosis in clear cell renal cell carcinoma as a target of microRNA-217. Kaohsiung J Med Sci. 2021;37(2):121–127.
   PubMed Web of Science ®Google Scholar
• Xu S, Zhang H, Liu T, et al. 6-Gingerol induces cell-cycle G1-phase arrest through AKT-GSK 3beta-cyclin D1 pathway in renal-cell carcinoma. Cancer Chemother Pharmacol. 2020;85(2):379–390.
   PubMed Web of Science ®Google Scholar
• Lv D, Xiang Y, Yang Q, et al. Long Non-Coding RNA TUG1 Promotes Cell Proliferation and Inhibits Cell Apoptosis, Autophagy in Clear Cell Renal Cell Carcinoma via MiR-31-5p/FLOT1 Axis. Onco Targets Ther. 2020;13:5857–5868.
   PubMedGoogle Scholar
• Zhong M, Zhu M, Liu Y, et al. TNFAIP8 promotes the migration of clear cell renal cell carcinoma by regulating the EMT. J Cancer. 2020;11(10):3061–3071.
   PubMed Web of Science ®Google Scholar
• Geng X, Sun Y, Fu J, et al. MicroRNA-17-5p inhibits thyroid cancer progression by suppressing Early growth response 2 (EGR2). Bioengineered. 2021;12(1):2713–2722.
   PubMed Web of Science ®Google Scholar
• Yamamoto K, Ito S, Hanafusa H, et al. Uncovering Direct Targets of MiR-19a Involved in Lung Cancer Progression. PLoS One. 2015;10(9):e0137887.
   PubMed Web of Science ®Google Scholar
• Hoefflin R, Harlander S, Schafer S, et al. HIF-1alpha and HIF-2alpha differently regulate tumour development and inflammation of clear cell renal cell carcinoma in mice. Nat Commun. 2020;11(1):4111.
   PubMed Web of Science ®Google Scholar
• Li YL, Wu LW, Zeng LH, et al. ApoC1 promotes the metastasis of clear cell renal cell carcinoma via activation of STAT3. Oncogene. 2020;39(39):6203–6217.
   PubMed Web of Science ®Google Scholar
• Chen L, Wu D, Circular DT. RNA circ_0001368 inhibited growth and invasion in renal cell carcinoma by sponging miR-492 and targeting LATS2. Gene. 2020;753:144781.
   PubMed Web of Science ®Google Scholar
• Yan ZC, He L, Qiu JH, et al. LncRNA HOTAIR participates in the development and progression of adrenocortical carcinoma via regulating cell cycle. Eur Rev Med Pharmacol Sci. 2018;22(20):6640–6649.
   PubMed Web of Science ®Google Scholar
• Min H, He W. Long non-coding RNA ARAP1-AS1 promotes the proliferation and migration in cervical cancer through epigenetic regulation of DUSP5. Cancer Biol Ther. 2020;21(10):907–914.
   PubMed Web of Science ®Google Scholar
• Fan CN, Ma L, Liu N. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer. J Transl Med. 2018;16(1):264.
   PubMed Web of Science ®Google Scholar
• Qi G, Li L. Long non-coding RNA PVT1 contributes to cell growth and metastasis in non-small-cell lung cancer by regulating miR-361-3p/SOX9 axis and activating Wnt/beta-catenin signaling pathway. Biomed Pharmacothe. 2020;126:110100.
   PubMed Web of Science ®Google Scholar
• Bessho H, Wong B, Huang D, et al. Inhibition of placental growth factor in renal cell carcinoma. Anticancer Res. 2015;35(1):531–541.
   PubMed Web of Science ®Google Scholar
• Desai J, Holt-Shore V, Torry RJ, et al. Signal transduction and biological function of placenta growth factor in primary human trophoblast. Biol Reprod. 1999;60(4):887–892.
   PubMed Web of Science ®Google Scholar
• Li C, Dong B, Xu X, et al. ARAP1-AS1 aggravates the malignant phenotypes of ovarian cancer cells through sponging miR-4735-3p to enhance PLAGL2 expression. Cytotechnology. 2021;73(3):363–372.
   PubMed Web of Science ®Google Scholar